понедельник, 26 декабря 2016 г.

Credit Suisse Group AG Reiterates Underperform Rating for AstraZeneca plc

Credit Suisse Group AG Reiterates Underperform Rating for AstraZeneca plc


's stock had its "underperform" rating restated by equities researchers at Credit Suisse Group AG in a research note issued to investors on Monday. They presently have a GBX 4,000 target price on the biopharmaceutical company's stock.



from Biotech News